These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28011908)

  • 1. Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices.
    Birse KD; Romas LM; Guthrie BL; Nilsson P; Bosire R; Kiarie J; Farquhar C; Broliden K; Burgener AD
    J Infect Dis; 2017 Feb; 215(4):590-598. PubMed ID: 28011908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.
    Roxby AC; Fredricks DN; Odem-Davis K; Ásbjörnsdóttir K; Masese L; Fiedler TL; De Rosa S; Jaoko W; Kiarie JN; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):359-66. PubMed ID: 26914908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
    Yang L; Hao Y; Hu J; Kelly D; Li H; Brown S; Tasker C; Roche NE; Chang TL; Pei Z
    Emerg Microbes Infect; 2019; 8(1):197-210. PubMed ID: 30866773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity.
    Zalenskaya IA; Chandra N; Yousefieh N; Fang X; Adedipe OE; Jackson SS; Anderson SM; Mauck CK; Schwartz JL; Thurman AR; Doncel GF
    J Clin Invest; 2018 Oct; 128(10):4622-4638. PubMed ID: 30222141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Cervical CD4
    Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An updated review on the effects of depot medroxyprogesterone acetate on the mucosal biology of the female genital tract.
    Ayele H; Perner M; McKinnon LR; Birse K; Farr Zuend C; Burgener A
    Am J Reprod Immunol; 2021 Sep; 86(3):e13455. PubMed ID: 33991137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Intramuscular Depot Medroxyprogesterone Acetate Initiation on Vaginal Microbiota in the Postpartum Period.
    Whitney BM; Srinivasan S; Tapia K; Muriuki EM; Chohan BH; Wallis JM; Liu C; Guthrie BL; McClelland RS; Hoffman NG; Fredricks DN; Roxby AC
    Clin Infect Dis; 2021 Jun; 72(12):e1093-e1102. PubMed ID: 33354707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.
    Mitchell CM; McLemore L; Westerberg K; Astronomo R; Smythe K; Gardella C; Mack M; Magaret A; Patton D; Agnew K; McElrath MJ; Hladik F; Eschenbach D
    J Infect Dis; 2014 Aug; 210(4):651-5. PubMed ID: 24652495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of progestin-based contraceptives on HIV-associated vaginal immune biomarkers and microbiome in adolescent girls.
    Nasr MA; Aldous A; Daniels J; Joy C; Capozzi E; Yang M; Moriarty P; Emmanuel-Baker V; Malcolm S; Green SJ; Gomez-Lobo V; Ghosh M
    PLoS One; 2024; 19(7):e0306237. PubMed ID: 39008499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques.
    Radzio J; Hanley K; Mitchell J; Ellis S; Deyounks F; Jenkins LT; Hanson D; Heneine W; García-Lerma JG
    AIDS; 2014 Jun; 28(10):1431-9. PubMed ID: 24759208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis of the cervical epithelial integrity of women using depot medroxyprogesterone acetate.
    Bradley F; Franzén Boger M; Kaldhusdal V; Åhlberg A; Edfeldt G; Lajoie J; Bergström S; Omollo K; Damdimopoulos A; Czarnewski P; Månberg A; Oyugi J; Kimani J; Nilsson P; Fowke K; Tjernlund A; Broliden K
    PLoS Pathog; 2022 May; 18(5):e1010494. PubMed ID: 35533147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections.
    Dabee S; Balle C; Onono M; Innes S; Nair G; Palanee-Phillips T; Burgener AD; Bosinger SE; Passmore JS; Heffron R; Jaspan H; Happel AU
    Curr HIV/AIDS Rep; 2023 Aug; 20(4):251-260. PubMed ID: 37341916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
    Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
    Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women.
    Guthrie BL; Introini A; Roxby AC; Choi RY; Bosire R; Lohman-Payne B; Hirbod T; Farquhar C; Broliden K
    J Acquir Immune Defic Syndr; 2015 May; 69(1):1-10. PubMed ID: 25622059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.
    Chandra N; Thurman AR; Anderson S; Cunningham TD; Yousefieh N; Mauck C; Doncel GF
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):592-601. PubMed ID: 23189932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot-medroxyprogesterone acetate reduces genital cell-cell adhesion molecule expression and increases genital herpes simplex virus type 2 infection susceptibility in a dose-dependent fashion.
    Quispe Calla NE; Vicetti Miguel RD; Aceves KM; Torres A; Cherpes TL
    Contraception; 2019 Nov; 100(5):397-401. PubMed ID: 31302121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.